Mediware Information Systems, Inc. and Cytolon AG agreed to collaborate on improving IT tools for banking and matching of hematopoietic stem cells derived from umbilical cord blood donations.
In a release, the Company noted that Cytolon AG's Internet-based platform, CordMatch matches cord blood units globally to allow for communication between clinicians and coordinators with the UCB product providers.
"We see great opportunities for our customers by working together with Mediware," said Thomas Klein, the founder and CEO of Cytolon. "Mediware is a great partner. The collaboration between our complementary IT solutions will connect matches across the world and help save lives with stem cell therapies."
((Comments on this story may be sent to firstname.lastname@example.org))